Patent Assignment
Reel/Frame 073214/0589
Assignment of Assignor's Interest
Recorded: 2025-12-15
Pages: 4
Assignor
CASZYME LLC
Executed: 2024-04-29
Assignee
RENAGADE THERAPEUTICS MANAGEMENT INC.
640 MEMORIAL DRIVE, SUITE 2300, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
Type V Crispr Gene Editing Components, Systems, and Methods of Use
Application:
18/297,346 →
Publication:
US 2024/0084274
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.